legislation: 111-hr-6255

Congressional bills and resolutions from Congress.gov, filtered to policy areas relevant to environmental, health, agriculture, and wildlife regulation.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

bill_id congress bill_type bill_number title policy_area introduced_date latest_action_date latest_action_text origin_chamber sponsor_name sponsor_state sponsor_party sponsor_bioguide_id cosponsor_count summary_text update_date url
111-hr-6255 111 hr 6255 To require mail-order pharmacies to notify customers when generic drugs become available and to prevent mail-order pharmacies from substituting drugs without the express authorization of the prescriber. Commerce 2010-09-29 2010-09-29 Referred to the House Committee on Energy and Commerce. House Rep. Shea-Porter, Carol [D-NH-1] NH D S001170 0 Requires a mail-order pharmacy to inform a customer to whom it dispenses a prescription brand name drug when a generic drug that is the pharmaceutical equivalent becomes available. Permits a mail-order pharmacy to substitute a generic drug for a brand name drug or a brand name drug for a generic drug if the mail order pharmacy: (1) notifies the customer that the pharmacy will request that the prescriber provide an authorization to make such a substitution; and (2) after providing such notification, obtains the express written authorization of the prescriber of the drug to make such a substitution. Requires the prescriber to provide notice to the customer of an authorization. Permits the Secretary of Health and Human Services (HHS) to assess civil penalties against a mail-order pharmacy for violations of this Act. Declares that this Act preempts state laws to the extent any are inconsistent with this Act. 2023-01-11T13:21:32Z  

Links from other tables